Leaflet IPIGRIX 15mg / ml solution for injection


Indicated for: peripheral neuropathies; neuromuscular disorders

Route of administration: injectable

Substance: ipidacrin (cholinesterase inhibitor)

ATC: N07AA (Nervous system | Parasympathomimetics | Anticholinesterases)

Ipidacrine is a medication used to treat disorders of the peripheral and central nervous system, such as neuropathies or myasthenia gravis. It works by inhibiting acetylcholinesterase, thereby increasing acetylcholine levels and improving neuromuscular transmission.

The medication is administered orally or by injection, as directed by a doctor.

Side effects may include nausea, diarrhea, abdominal pain, or dizziness. In rare cases, allergic reactions or bradycardia may occur.

Patients should inform their doctor about any other medications they are taking and strictly follow the treatment regimen. Pregnant or breastfeeding women should consult a specialist before use.

General data about IPIGRIX 15mg / ml

  • Substance: ipidacrin
  • Commercial code: W69144001
  • Concentration: 15mg / ml
  • Pharmaceutical form: solution for injection
  • Product type: generic
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Marketing authorisation

  • Manufacturer: AS GRINDEKS - LETONIA
  • Holder: AS GRINDEKS - LETONIA
  • Number: 14635/2022/01
  • Shelf life: 2 years

Pharmaceutical forms available for ipidacrin

Concentrations available for ipidacrin

  • 15mg/ml
  • 20mg
  • 5mg/ml